The state of Pennsylvania currently has 2 active clinical trials seeking participants for Hepatitis C research studies. These trials are conducted in various cities, including Philadelphia, Pittsburgh, Hershey and Allentown.
Sofosbuvir/Velpatasvir Treatment of Chronic Hepatitis C During Pregnancy
NCT05140941
Recruiting
This is a multicenter, single arm study of Sofosbuvir/Velpatasvir (SOF/VEL) for treatment of chronic hepatitis C infection during pregnancy. Treatment will be initiated during the second or third trimester in approximately 100 pregnant people. Maternal participants will take one SOF/VEL tablet once daily for 12 weeks (84 days) and followed until 12 weeks after treatment completion (postpartum). Infants will be followed from birth until one year of age. The primary objectives are to evaluate the... Read More
Gender:
Female
Ages:
Between 18 years and 45 years
Trial Updated:
04/04/2024
Locations: University of Pittsburgh, Magee Womens Hospital, Pittsburgh, Pennsylvania
Conditions: Hepatitis C, Chronic, Pregnancy; Infection
Register for Updates
Digital Community to Improve Health in Rural Areas
NCT05363865
Recruiting
The study is a cluster randomized controlled trial developed in counties located in Appalachia and the Midwest. We will prioritize counties from states with high risk for HIV and HCV infection associated with injection drug use.
Gender:
All
Ages:
Between 18 years and 99 years
Trial Updated:
03/08/2024
Locations: University of Pennsylvania, Philadelphia, Pennsylvania
Conditions: HIV Infections, Hepatitis C Virus Infection
Register for Updates